Patents by Inventor Annette Madrid

Annette Madrid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230192642
    Abstract: Described herein are isotopically enriched analogs of methylone (e.g., deuterated analogs of methylone (e.g., (S)-methylone and (R)-methylone) with improved characteristics. Also described herein are salts (such as hydrochloride salt) and solid forms (e.g., crystalline forms) of methylone. Also described herein are stereoisomers (e.g., enantiomers) of methylone. The present disclosure also provides methods of making and methods of use of the methylone or methylone analogs and solid forms of 3,4-methylenedioxy-N-ethylcathinone hydrochloride described herein to treat brain and neurological disorders such as depression.
    Type: Application
    Filed: December 28, 2022
    Publication date: June 22, 2023
    Inventors: Matthew DUNCTON, Samuel CLARK, Alistair HENDERSON, Bernard GOLDING, Manuel MONERRIS MASCARO, Lucia JOHNSON, Annette MADRID
  • Publication number: 20050187196
    Abstract: The invention provides methods and medicaments for improving attentiveness in humans, including subjects diagnosed with attention disorders. In one aspect, a GABAB receptor antagonist, such as 3-aminopropyl-(n-butyl)-phosphinic acid (ABPA), is used to improve attention.
    Type: Application
    Filed: February 23, 2005
    Publication date: August 25, 2005
    Applicant: Saegis Pharmaceuticals, Inc.
    Inventors: Annette Madrid, Helen Jenkins, Rodney Pearlman